These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 3856066)
1. Stimulation of proliferation in mixed cultures of mouse tumor cells and nonimmune peritoneal cells. I. Occurrence of stimulation and cyclical variation in tumor cell activity. Nelson M; Nelson DS J Natl Cancer Inst; 1985 Mar; 74(3):627-35. PubMed ID: 3856066 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of proliferation in mixed cultures of mouse tumor cells and nonimmune peritoneal cells. II. Stimulation of tumor cells by macrophages and of lymphocytes by a tumor cell product. Nelson M; Nelson DS J Natl Cancer Inst; 1985 Mar; 74(3):637-45. PubMed ID: 3919198 [TBL] [Abstract][Full Text] [Related]
3. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)]. Fray A; Lorinet AM; Thobie N; Halpern B Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346 [TBL] [Abstract][Full Text] [Related]
4. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures. Hurrell SM; Zarling JM J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084 [TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo. Gabizon A; Leibovich SJ; Goldman R J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261 [TBL] [Abstract][Full Text] [Related]
6. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ; Taramelli D; Holden HT; Varesio L J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831 [TBL] [Abstract][Full Text] [Related]
7. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum. Tomecki J; Sukiennik J; Kordowiak A Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907 [TBL] [Abstract][Full Text] [Related]
8. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages. Evans R; Eidlen DM J Natl Cancer Inst; 1983 Nov; 71(5):983-9. PubMed ID: 6580500 [TBL] [Abstract][Full Text] [Related]
9. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ]. Mazurek C; Stiffel C; Chalvet H; Biozzi G Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973 [TBL] [Abstract][Full Text] [Related]
10. In vitro anti-tumour properties of peritoneal exudate cells of conventional germ-free and stimulated mice. Fray A; Lorinet AM; Halpern B Dev Biol Stand; 1977 Apr 13-15; 38():241-4. PubMed ID: 608509 [TBL] [Abstract][Full Text] [Related]
11. Effect of immunomodulation on the fate of tumor cells in the central nervous system and systemic organs of mice. Distribution of [125I]5-Iodo-2'-deoxyuridine-labeled KHT tumor cells after left intracardial injection. Conley FK J Natl Cancer Inst; 1982 Aug; 69(2):465-73. PubMed ID: 6955547 [TBL] [Abstract][Full Text] [Related]
12. Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells. Matthews TJ; Weinhold KJ; Langlois AJ; Bolognesi DP J Natl Cancer Inst; 1985 Oct; 75(4):703-8. PubMed ID: 3862902 [TBL] [Abstract][Full Text] [Related]
13. Induction of spleen cell growth and DNA polymerase activity by Corynebacterium parvum. Maruyama Y; Coleman MS Cancer Res; 1978 Jun; 38(6):1617-20. PubMed ID: 647675 [TBL] [Abstract][Full Text] [Related]
14. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice. Budzyński W Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489 [TBL] [Abstract][Full Text] [Related]
16. Distribution of IgM, IgA and IgG secreting cells in the tissues of normal and tumour-bearing mice. Howie S; McBride WH; James K Immunology; 1982 May; 46(1):43-8. PubMed ID: 7042550 [TBL] [Abstract][Full Text] [Related]
17. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. Yoshida R; Yoneda Y; Kuriyama M; Kubota T J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111 [TBL] [Abstract][Full Text] [Related]
18. Effect of castration and 17 beta-estradiol pulse on cell proliferation in the uterus and the MXT mouse mammary tumor. Paridaens RJ; Danguy AJ; Leclercq G; Kiss R; Heuson JC J Natl Cancer Inst; 1985 Jun; 74(6):1239-46. PubMed ID: 3858596 [TBL] [Abstract][Full Text] [Related]
19. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones. Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. Hanna N; Schneider M J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]